Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant disease.

This phase II study evaluates the efficacy and toxicity of a prolonged schedule of oral etoposide in patients with measurable advanced ovarian cancer resistant to, or relapsed following, platinum-based chemotherapy. Forty-seven patients participated, 20 of whom had received more than one prior treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Seymour, M. T., Mansi, J. L., Gallagher, C. J., Gore, M. E., Harper, P. G., Evans, T. R., Edmonds, P. M., Slevin, M. L.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968773/
https://www.ncbi.nlm.nih.gov/pubmed/8286205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968773/
https://www.ncbi.nlm.nih.gov/pubmed/8286205

Ejemplares similares